Release of Cardiac Troponin in Basketball Players is Independent of Training Level and Maturation Status

Basketball is among the most popular sports in the world, and its related industries have also produced huge economic benefits. In recent years, the application of artificial intelligence (AI) technology in basketball has attracted a large amount of attention. We conducted a comprehensive review of the application research of AI in basketball through literature retrieval. Current research focuses on the AI analysis of basketball team and player performance, prediction of competition results, analysis and prediction of shooting, AI coaching system, intelligent training machine and arena, and sports injury prevention. Most studies have shown that AI technology can improve the training level of basketball players, help coaches formulate suitable game strategies, prevent sports injuries, and improve the enjoyment of games. At the same time, it is also found that the number and level of published papers are relatively limited. We believe that the application of AI in basketball is still in its infancy. We call on relevant industries to increase their research investment in this area, and promote the improvement of the level of basketball, making the game increasingly exciting as its worldwide popularity continues to increase.

Download Full-text

Cardiac Troponin T Is Still Useful for ESRD Patients

Internal Medicine News ◽

10.1016/s1097-8690(05)70478-9 ◽

2005 ◽

Vol 38 (1) ◽

pp. 36

Author(s):

MITCHEL L. ZOLER

Keyword(s):

Cardiac Troponin ◽

Troponin T ◽

Cardiac Troponin T ◽

Esrd Patients

Download Full-text

Cardiac troponin I in patients with acute upper and lower limb ischemia

VASA ◽

10.1024/0301-1526.37.4.327 ◽

2008 ◽

Vol 37 (4) ◽

pp. 327-332 ◽

Cited By ~ 1

Author(s):

Koutouzis ◽

Sfyroeras ◽

Moulakakis ◽

Kontaras ◽

Nikolaou ◽

...

Keyword(s):

Upper Limb ◽

Lower Limb ◽

Cardiac Troponin ◽

Cardiac Involvement ◽

Troponin I ◽

Limb Ischemia ◽

Elevated Troponin ◽

Troponin Elevation ◽

Lower Limb Ischemia ◽

Ischemia Group

Background: The aim of this study was to investigate the presence, etiology and clinical significance of elevated troponin I in patients with acute upper or lower limb ischemia. The high sensitivity and specificity of cardiac troponin for the diagnosis of myocardial cell damage suggested a significant role for troponin in the patients investigated for this condition. The initial enthusiasm for the diagnostic potential of troponin was limited by the discovery that elevated cardiac troponin levels are also observed in conditions other than acute myocardial infarction, even conditions without obvious cardiac involvement. Patients and Methods: 71 consecutive patients participated in this study. 31 (44%) of them were men and mean age was 75.4 ± 10.3 years (range 44–92 years). 60 (85%) patients had acute lower limb ischemia and the remaining (11; 15%) had acute upper limb ischemia. Serial creatine kinase (CK), isoenzyme MB (CK-MB) and troponin I measurements were performed in all patients. Results: 33 (46%) patients had elevated peak troponin I (> 0.2 ng/ml) levels, all from the lower limb ischemia group (33/60 vs. 0/11 from the acute upper limb ischemia group; p = 0.04). Patients with lower limb ischemia had higher peak troponin I values than patients with upper limb ischemia (0.97 ± 2.3 [range 0.01–12.1] ng/ml vs. 0.04 ± 0.04 [0.01–0.14] ng/ml respectively; p = 0.003), higher peak CK values (2504 ± 7409 [range 42–45 940] U/ml vs. 340 ± 775 [range 34–2403] U/ml, p = 0.002, respectively, in the two groups) and peak CK-MB values (59.4 ± 84.5 [range 12–480] U/ml vs. 21.2 ± 9.1 [range 12–39] U/ml, respectively, in the two groups; p = 0.04). Peak cardiac troponin I levels were correlated with peak CK and CK-MB values. Conclusions: Patients with lower limb ischemia often have elevated troponin I without a primary cardiac source; this was not observed in patients presenting with acute upper limb ischemia. It is very important for these critically ill patients to focus on the main problem of acute limb ischemia and to attempt to treat the patient rather than the troponin elevation per se. Cardiac troponin elevation should not prevent physicians from providing immediate treatment for limb ischaemia to these patients, espescially when signs, symptoms and electrocardiographic findings preclude acute cardiac involvement.

Download Full-text